Hey there, Fools. I’m back to call attention to three stocks trading at new three-month lows.
As legendary value investor Warren Buffet once quipped, “Whether we’re talking about socks or stocks, I like buying quality merchandise when it is marked down.” And there is no better place to buy marked down stocks than in a TFSA account, where the upside is all tax free.
Let’s get to it.
Leading off our list is oil and gas producer Imperial Oil (TSX:IMO)(NYSE:IMO), whose shares have fallen sharply in recent weeks and are currently trading at three-month lows of about $36.
Imperial’s shareholder-friendly nature, diversified business model, and leading market position in several segments are just a few reasons to pounce. Despite cold weather and mandated curtailments, Imperial still managed to generate operating cash flow of $1 billion. Moreover, it returned $510 million through buybacks and dividends.
“The company’s upstream production, midstream logistics, and downstream refining and sales work together to provide resiliency across a range of market conditions,” wrote Imperial.
Imperial shares are down 17% over the past year and currently offer a yield of 2.5%.
5 TSX Stocks Under $5Click here to learn more!
Trust the process
The stock has been weighed down on growth concerns as well as a lackluster launch into the recreational market, but now might be a prime opportunity to pounce.
Just last month, CannTrust signed a letter of intent with California-based Elk Grove Farming that will provide access to over 3,000 acres of farmland for hemp production.
“Our U.S. operation is expected to deliver a significant increase in low-cost production capacity, which will leverage our expertise in standardized CBD-based product formulation, and will give the Company a foothold in the largest international,” said CannTrust CEO Peter Aceto.
CannTrust is off 19% over the past year.
The big blow came yesterday when Canopy announced that Bruce Linton would step down as co-CEO and Board member. The buzz on Bay Street is that Canopy’s giant partner, Constellation Brands, was behind the move due to disappointment with Canopy’s most recent quarter.
“We thank Bruce and Mark for establishing the foundation for a company that is very well-positioned to lead in the emerging global cannabis market,” said Canopy Board Director David Klein. “We are also excited to embark upon our next phase of growth as global leader in the cannabis industry.”
Given Canopy’s still-exciting growth prospects, betting on that bullishness might be a profitable move.
The bottom line
There you have it, Fools: three contrarian stocks worth checking out.
As always, don’t see them as formal recommendations. Instead, view them as a starting point for more research. Trying to catch a falling knife can be hazardous to your wealth, so plenty of homework is still required.
This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.
Brian Pacampara owns no position in any of the companies mentioned.